Bandingkan Harga & Kinerja Bank Central Asia Tbk (BBCA) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bank Central Asia Tbk dan UBC Medical Indonesia Tbk.: Bank Central Asia Tbk diperdagangkan di Rp6.350 (kapitalisasi pasar 768,87 T, volume 24 jam 87,18 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp161 (kapitalisasi pasar 635,95 M, volume 24 jam 1,34 jt). Perbedaan utamanya: Bank Central Asia Tbk jauh lebih besar — sekitar 1209× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Bank Central Asia Tbk lebih aktif diperdagangkan (87,18 jt vs 1,34 jt). Mana yang lebih baik tergantung tujuan investasimu.
| BBCA | LABS | |
|---|---|---|
Kapitalisasi Pasar | 768,87 T | 635,95 M |
Volume | 87,18 jt | 1,34 jt |
Lot | 871,77 rb | 13,4 rb |
Perputaran | 549,68 M | 215,64 jt |
Harga Rata-rata | 6.305,29 | 160,93 |
Nilai Transaksi | 549,68 M | 215,64 jt |
Harga Ekuilibrium Indikatif | 6.350 | 161 |
Volume Ekuilibrium Indikatif | 130,53 rb | 17 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bank Central Asia Tbk
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Selengkapnya di halaman BBCA →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
